Search

Author/Creator Yoshino, Hiide

1. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Issue 7 (December 2014)

Authors:
Abe, Koji; Itoyama, Yasuto; Sobue, Gen; Tsuji, Shoji; Aoki, Masashi; Doyu, Manabu; Hamada, Chikuma; Kondo, Kazuoki; Yoneoka, Takatomo; Akimoto, Makoto; Yoshino, Hiide; on behalf of The Edaravone ALS Study Group
Journal:
Amyotrophic lateral sclerosis and frontotemporal degeneration
Issue:
Volume 15:Issue 7/8(2014)
Page Start:
610
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment. Issue 2 (28th December 2022)

Authors:
Genge, Angela; Pattee, Gary L.; Sobue, Gen; Aoki, Masashi; Yoshino, Hiide; Couratier, Philippe; Lunetta, Christian; Petri, Susanne; Selness, Daniel; Bidani, Sachin; Hirai, Manabu; Sakata, Takeshi; Salah, Alejandro; Apple, Stephen; Wamil, Art; Kalin, Alexander; Jackson, Carlayne E.
Journal:
Muscle & nerve
Issue:
Volume 67:Issue 2(2023)
Page Start:
124
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗